Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

CONMED Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

CONMED şirketinin toplam hissedar öz sermayesi $881.8M ve toplam borcu $963.7M olup, bu da borç-öz sermaye oranını 109.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $2.3B ve $1.4B dir. CONMED 'in FAVÖK'ü $144.6M faiz karşılama oranı 3.7 dur. Şirketin $28.9M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

109.3%

Borç/özkaynak oranı

US$963.71m

Borç

Faiz karşılama oranı3.7x
NakitUS$28.87m
EşitlikUS$881.83m
Toplam yükümlülüklerUS$1.40b
Toplam varlıklarUS$2.29b

Son finansal sağlık güncellemeleri

Recent updates

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Oct 01
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Sep 12
Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Aug 15
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

Jul 17
CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01
There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03
CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

CONMED declares $0.20 dividend

Aug 11

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CNMD 'nin kısa vadeli varlıkları ( $623.8M ) kısa vadeli yükümlülüklerini ( $266.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: CNMD 'un kısa vadeli varlıkları ( $623.8M ) uzun vadeli yükümlülüklerini ( $1.1B ) karşılamamaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CNMD 'nin net borç/öz sermaye oranı ( 106% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: CNMD 'nin borç/öz sermaye oranı son 5 yılda 116.1% seviyesinden 109.3% seviyesine düştü.

Borç Kapsamı: CNMD 'nin borcu işletme nakit akışı ( 18.2% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: CNMD 'in borcuna ilişkin faiz ödemeleri EBIT ( 3.7 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin